Dr Krishna M Ella | Founder and Chairman
Bharat Biotech International Ltd

Dr Krishna M Ella, Founder and Chairman, Bharat Biotech International Ltd

Dr. Krishna Ella is the Chairman & Managing Director of Bharat Biotech International Limited. After early education in Agricultural Sciences, Dr. Ella studied at the University of Hawaii and the University of Wisconsin-Madison. Following a brief stint as a research faculty at the Medical University of South Carolina-Charleston, he returned to India and set up Bharat Biotech International Limited, a multidimensional biotechnology company specializing in R&D, manufacturing and marketing of vaccines and biotherapeutics for human use. Today, Bharat Biotech is one of the leading innovative R&D Companies, with 45 global patents, of which 5 are for new molecules. Bharat Biotech has been funded (>300 crores) by various agencies like DBT, CSIR, DST and Bill & Melinda Gates Foundation.


Day Two 11th October, Human @ 09:10

Plenary discussion: Where is the global vaccine industry shifting to for new collaborations? Perspectives from emerging markets and Asia

  • The role of emerging markets in the global supply and demand for vaccines
  • What vaccine technologies and vaccine candidates are favourable?
  • Does it align with other philanthropy organisations?
  • The role of Public-Public Partnerships (P2Ps) in vaccine R&D for poverty related and neglected diseases (PRNDs)
  • Priorities for linking new vaccine development with public health in low and middle income countries

back to speakers